WE SPEAK FLUENT LAB TO LIFE
DEAD

Serial Number

90639492

Owner

SYNEOS HEALTH, LLC

Attorney

Michael A. Geller

Filing Date

Apr 12, 2021

Add to watchlist:

No watchlists yet
View on USPTO

WE SPEAK FLUENT LAB TO LIFE Trademark

Serial Number: 90639492

WE SPEAK FLUENT LAB TO LIFE is a trademark filed by SYNEOS HEALTH, LLC on April 12, 2021. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

SYNEOS HEALTH, LLC (17 trademarks)

1030 SYNC STREET
MORRISVILLE, NC 27560

Entity Type: 16

Trademark Details

Filing Date

April 12, 2021

Registration Date

Not Registered

Published for Opposition

January 4, 2022

Goods & Services

Education in the field of pharmaceutical sales, namely, providing webinars, providing live workshops, providing on-line non-downloadable videos, providing on-line non-downloadable publications in the nature of articles and white papers, and providing podcasts; training services in the field of pharmaceutical sales; providing on-line non-downloadable newsletters and bulletins in the pharmaceutical, biotechnology and life sciences fields; educational services in the field of clinical trials, namely, providing on-line non-downloadable videos, webinars, live workshops, providing online non-downloadable publications in the nature of articles and white papers, and providing podcasts

Strategic business consulting, marketing and advertising, public relations communications strategy, information and data collection for business purposes, and business data analytics, namely, analyzing business data to understand and evaluate business performance, all of the aforementioned in the pharmaceutical, biotechnology and life sciences fields; sales promotion services; market analysis and research services; personnel recruitment and placement; recruitment services, namely, advertising clinical trials, recruiting patients, and placing patients for participation in clinical trials for testing of pharmaceuticals and devices; consulting in sales techniques and sales programs; sales volume tracking for others, all in the pharmaceutical, biotechnology and life sciences fields; business consulting in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, pharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; assisting pharmaceutical and biotechnology companies with applications for new drugs with governmental regulatory bodies; promoting the exchange of health information to promote patient adherence

Providing medical information to physicians, other health care professionals and for medical patients; providing health information regarding the medications and health care products of others, namely, product discontinuations, new formulations, bottle changes, and seasonal information through e-mail alerts and push notifications

Medical, scientific and data analysis research services for others, namely, conducting and analyzing clinical trials in the pharmaceutical, biotechnology and life sciences fields; pharmaceutical drug development services, namely, developing clinical trial methodologies; consulting services in the area of pharmaceutical clinical testing; extended clinical research services for others, namely, computerized data management of clinical trials, biostatistical analysis, environmental consultancy, preclinical research and development evaluation, repairing flawed clinical trials and dossiers, strategic clinical research portfolio management, and biosurveillance monitoring; providing life science and scientific research information to physicians and other health care professionals, patients, and medical, pharmaceutical and biotechnology companies; providing regulatory compliant technical writing services in the field of medical research and clinical studies; consulting services in the field of contract clinical research and contract product development; Internet development, design and consulting services for others, namely, creating websites featuring blogs about medical and pharmaceutical information related to chronic illnesses and disease, creating an online community for patients and caregivers to communicate about healthcare, and design and development of interactive software for use in the communication and dissemination of medical and pharmaceutical information

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 2, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 2, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 2, 2023 EXRA
SOU EXTENSION 2 GRANTED
Jan 31, 2023 EX2G
SOU EXTENSION 2 FILED
Jan 31, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 31, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 6, 2022 EXRA
SOU EXTENSION 1 GRANTED
Aug 4, 2022 EX1G
SOU EXTENSION 1 FILED
Aug 4, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 4, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 1, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 4, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jan 4, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 15, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 29, 2021 CNSA
ASSIGNED TO EXAMINER
Nov 15, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 19, 2021 NWOS
NEW APPLICATION ENTERED
Apr 15, 2021 NWAP